Aleix Prat, Director of the Clínic Barcelona Comprehensive Cancer Center at Barcelona Clinical Hospital, shared a post on LinkedIn:
“Amazing week for the Clínic Barcelona Comprehensive Cancer Centre (4CB) at American Society Hhematology (ASH) Annual Meetting 2025.
Here a summary.
Our hematology and transplant teams presented several important studies on CAR-T therapy, hematopoietic transplantation, and new biomarkers across myeloma, lymphoma, and MDS.
The real-world data from our CAR-T program, the work on donor-age impact in transplantation, and the translational studies on disease biology reflect the strength of our clinical and research teams.
Several presentations received ASH Abstract Achievement Awards, a fantastic recognition for our young investigators and for the collaborative work between Hospital Clínic, IDIBAPS, and the 4CB.
Proud of the team and of the continued progress in advanced therapies and innovation.”
More posts featuring Aleix Prat.